Nuvectis Pharma, Inc.NVCTNASDAQ

Loading chart...

Want to monitor NVCT?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

No description available.

Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

Key Statistics

About

News

Inside Tesla's $20B Capex Plan: How TSLA Is Shaping Its Future

Oracle's Big $50 Billion Bet: Bold Bid for AI Leadership or Setup for Epic Collapse?

SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA

Tesla Q4 Earnings: My CliffsNotes On 200+ P/E And Record CapEx

A New Wave of Federal Nuclear Support & Coordination

Critical Financial Goals Call for Consistent Cash Flow

Elevate Your Retirement Goals With Distributing Ladder ETFs

Why Musk's Decision to End Model S/X Production Makes Sense for Tesla

5 Low Price-to-Book Stocks That Are Worth Watching in February

Mag 7 Outlook: What Apple, Microsoft, Meta, and Tesla Just Told Us

The metal sell-off, Disney earnings, the 'Melania' movie and more in Morning Squawk

Insmed: A Brensocatib Pipeline Setback Is Masking A Dupixent-Like Launch

Revvity (RVTY) Q4 Earnings and Revenues Beat Estimates

Tharimmune Elects Jill Sommers and William Wiley to Board of Directors

Inuvo Announces Receipt of $6.2 Million Class Action Settlement

Tastepoint by IFF Predicts Ten Flavor Trends for 2026

5 High-Yield Passive Income Kings for Retirees That Posted Outstanding Q4 Results

Banco BPM to double board seats chosen by minority investors, documents show

IDEXX forecasts 2026 revenue, profit above estimates on strong demand for pet diagnostics

Jeffs' Brands' KeepZone AI Will Serve as Hydrogen-Powered Drone Systems' Prime Contractor to Support Government and Defense Clients